Inclusion Criteria:

3.1.1 Male or female patients 18 years of age and above. 3.1.2 Patients
diagnosed with liver cancer based on biopsy or serum alpha-fetoprotein level, associated
with characteristic hypervascular liver tumors on triphasic spiral CT scan or MRI.
Patients with non-cancer liver conditions such as cirrhosis, adenoma, cholangioma, or
nodular hyperplasia. Patients with metastatic tumor from anther organ, such as metastatic
colon cancer.

3.13 Ability to understand and the willingness to sign a written informed consent
document.

Exclusion Criteria:3.2.1Female patients who are pregnant or nursing will be excluded from
the study.